Brenden Schultek

Brenden Schultek has a diverse work experience spanning over two decades. Brenden is currently the Vice President of US Commercial Sales at BioXcel Therapeutics, Inc. Prior to this, they worked as an Advisor and Mentor at First Flight Venture Center, where they provided guidance and support to start-up CEOs. Before that, they held the position of Vice President of Sales at Cara Therapeutics.

Brenden also gained valuable experience at Nabriva Therapeutics plc, where they served as the Vice President of Sales and later as the AVP of Commercial Development. Brenden worked as a Senior Consultant at Coeus Consulting Group and held various roles at QuVa Pharma, Inc, including Director of US Field Sales, Director of National Accounts, and Area Business Director.

In addition, Brenden held the position of Regional Business Director and Market Development Director at Durata Therapeutics. Brenden led a team of 10 sales representatives and played a crucial role in the launch of a proprietary product. Their experience also involved market development and analysis work on large IDNs and ACOs within their assigned region.

Early in their career, Brenden worked for Pfizer Pharmaceuticals, where they held positions such as District Business Manager, Hospital Account Specialty Sales, and Territory Representative.

Overall, Brenden Schultek has a strong background in sales, commercial development, and mentorship, with a proven track record of success in the pharmaceutical and biotech industries.

Brenden Schultek attended Villanova University from 1999 to 2003, where they obtained a Bachelor of Science degree in Finance/International Business. Afterward, they pursued further education at James Cook University, but specific details about the degree and field of study are unavailable.